Testosterone replacement therapy

British Journal of Hospital Medicine

Volumn 68, Issue 10, 2007, Pages 547-553

  Jones, T H ^a,b  

^a BARNSLEY HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE; TESTOSTERONE UNDECANOATE; TOSTRAN; UNCLASSIFIED DRUG;

ACNE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; DISEASE CLASSIFICATION; DRUG FORMULATION; ERYTHROCYTOSIS; FLUID RETENTION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INFERTILITY; LIVER TOXICITY; OILY SKIN; PROSTATE CANCER; PROSTATE HYPERTROPHY; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SKIN MANIFESTATION; SLEEP APNEA SYNDROME; TESTIS ATROPHY;

EID: 35548966121     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2007.68.10.27326     Document Type: Review

References (30)

1. Advisory Panel on Testosterone Replacement in Men (2001) Report of the National Institute on Aging Advisory Panel on Testosterone Replacement in Men. J Clin Endocrinol Metab 86: 4611-17
2. Bhasin S, Storer TW, Javanbakht M et al (2000) Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels. JAMA 283: 763-70
3. Bhasin S, Cunningham GR, Hayes FJ et al (2006) Testosterone therapy in adult men with androgen deficiency syndromes: An Endocrine Society clinical practice guideline J Clin Endocrinol Metab 91: 1995-2010
4. Bojesen A, Juul S, Gravholt CH (2003) Prenatal and postnatal prevalence of Klinefelter syndrome: a national registry study. J Clin Endocrinol Metab 88: 622-6
5. English KM, Steeds RP, Diver MJ, Jones TH, Channer KS (2000) Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomised, double-blind, placebo-controlled study. Circulation 102: 1906-11
6. Feldman HA, Longcope C, Derby CA et al (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 87: 589-98
7. Handelsman DJ, Mackey MA, Howe C, Turner L, Conway AJ (1997) An analysis of testosterone implants for androgen replacement therapy. Clin Endocrinol 47: 311-16
8. Isidori A, Giannetta E, Greco EA et al (2005) Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol 63: 280-93
9. Jockenhövel F (2004) Male Hypogonadism. Uni-Med Verlag, Bremen, Germany
10. Jockenhövel F, Kaufman JM, Mickisch GH, Morales A, Wang C (2005) The good, the bad, and the unknown of late onset hypogonadism: the urological perspective. J Men's Health Gender 2(3): 292-301
11. Jones TH, Darne JF (1993) Self-administered subcutaneous human menopausal gonadotrophin for the stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotrophic. Hypogonadism. Clin Endocrinol (Oxf) 38: 203-8
12. Jones TH, Darne JF, McGarrigle HH (1994) Diurnal rhythm of testosterone induced by human chorionic gonadotrophin (hCG) therapy in isolated hypogonadotrophic hypogonadism: a comparison between subcutaneous and intramuscular hCG administration. Eur J Endocrinol 131: 173-8
13. Kapoor D, Malkin CJ, Channer KS, Jones TH (2005) Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63: 239-50
14. Kapoor D, Goodwin E, Channer KS, Jones TH (2006) Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol 154: 899-906
15. Malkin CJ, Pugh PJ, Morris PD et al (2004) Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 90: 871-6
16. Malkin CJ, Pugh PJ, West JN et al (2006) Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J 27: 57-64
17. Morales A, Lunenfeld B (2002) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 5: 74-86
18. Morris PD, Malkin CJ, Channer KS, Jones TH (2004) A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men. Eur J Endocrinol 151: 241-9
19. Nieschlag E, Behre HM, Bouchard P et al (2004) Testosterone replacement: current trends and future directions. Human Reprod Update 10: 409-16
20. Nieschlag E, Swerdloff R, Behre HM et al (2005) Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male 8: 56-8
21. Okun MS, Walter BL, McDonald WM et al (2002) Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease. Arch Neurol 59: 1750-3
22. Pope HG, Cohane GH, Kanayama G et al (2003) Testosterone gel supplementation for men with refractory depression: a randomised, placebo-controlled trial. Am J Psychiatry 160: 105-11
23. Pugh PJ, Jones RD, West JN et al (2004) Testosterone treatment for men with chronic heart failure. Heart 90: 446-7
24. Rhoden EL, Morgentaler A (2004) Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med 35: 482-92
25. Ross RJ, Jabbar A, Jones TH et al (2004) Pharmacokinetics and tolerability of a bioadhesive tablet in hypogonadal men Eur J Endocrinol 150: 57-63
26. Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H (2004) Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol 172: 658-63
27. Steidle C, Schwartz K, Jacoby T et al (2003) AA2500 testosterone gel normalises androgen levels in aging males with improvements in body composition and sexual function. J Clin Endocrinol Metab 88: 2673-81
28. Vermeulen A, Kaufman JM, Giagulli VA ( 1996) Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 81: 1821-6
29. Wang C, Swerdloff RS, Tranmanesh A et al (2000) Transermal testostetone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85: 2839-53
30. Zitzmann M, Brune M, Vieth V, Nieschlag E (2002) Monitoring bone density in hypogonadal men with quantitative phalangeal ultrasound. Bone 31: 422-9